Literature DB >> 6733046

Production and availability of thromboplastin in endothelial cells: the effects of thrombin, endotoxin and platelets.

J H Brox, B Osterud, E Bjørklid, J W Fenton.   

Abstract

Freshly prepared endothelial cells from umbilical cord veins were demonstrated to possess a weak but significant thromboplastin activity. Upon exposure of cultured endothelial cells to catalytically active thrombin (4.5 U/ml) or endotoxin (0.05 microgram/ml), the thromboplastin activity of the cells was increased 10-40-fold during 5 h incubation, and with the additional presence of washed, isolated platelets during the incubation, the activity was enchanced up to 170-fold. Platelets or catalytically inactivated thrombin added alone were largely ineffective as stimulants. 75-80% of the enhanced thromboplastin activity became available on the surface of the cultured cells as demonstrated by utilizing thromboplastin antibodies. Such exposed activity is suggested to be important in thrombotic situations where initial formation of thrombin may significantly accelerate the generation of thrombin by a positive feedback effect upon thromboplastin synthesis in the endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6733046     DOI: 10.1111/j.1365-2141.1984.tb02892.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  13 in total

Review 1.  Endothelial cell function in diabetic microangiopathy.

Authors:  M Porta; M La Selva; P Molinatti; G M Molinatti
Journal:  Diabetologia       Date:  1987-08       Impact factor: 10.122

Review 2.  The haemostatic function of the vascular endothelial cell.

Authors:  H A Bull; S J Machin
Journal:  Blut       Date:  1987-08

3.  Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro.

Authors:  K L Moore; S P Andreoli; N L Esmon; C T Esmon; N U Bang
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

4.  Investigation of tissue factor and other hemostatic profiles in experimental hypothyroidism.

Authors:  A Ata Alturfan; Ebru Emekli Alturfan; Nuran Dariyerli; Emel Zengin; Erman Aytac; Gunnur Yigit; Emine Kokoglu
Journal:  Endocrine       Date:  2006-08       Impact factor: 3.633

5.  Comparative effects of unfractionated heparin and low molecular weight heparin on vascular endothelial cell tissue factor pathway inhibitor release: a model for assessing intrinsic thromboresistance.

Authors:  YouFu Li; Miguel Rodriquez; Frederick A Spencer; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2002-10       Impact factor: 2.300

6.  Activated protein C up-regulates procoagulant tissue factor activity on endothelial cells by shedding the TFPI Kunitz 1 domain.

Authors:  Reto A Schuepbach; Kara Velez; Matthias Riewald
Journal:  Blood       Date:  2011-04-07       Impact factor: 22.113

7.  Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque.

Authors:  J N Wilcox; K M Smith; S M Schwartz; D Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

8.  Tissue factor is rapidly induced in arterial smooth muscle after balloon injury.

Authors:  J D Marmur; M Rossikhina; A Guha; B Fyfe; V Friedrich; M Mendlowitz; Y Nemerson; M B Taubman
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

9.  Heterogeneous regulation of constitutive thrombomodulin or inducible tissue-factor activities on the surface of human saphenous-vein endothelial cells in culture following stimulation by interleukin-1, tumour necrosis factor, thrombin or phorbol ester.

Authors:  G Archipoff; A Beretz; J M Freyssinet; C Klein-Soyer; C Brisson; J P Cazenave
Journal:  Biochem J       Date:  1991-02-01       Impact factor: 3.857

10.  Agonist-mediated tissue factor expression in cultured vascular smooth muscle cells. Role of Ca2+ mobilization and protein kinase C activation.

Authors:  M B Taubman; J D Marmur; C L Rosenfield; A Guha; S Nichtberger; Y Nemerson
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.